Prevalence of Helicobacter pylori infection among patients with dyspepsia in South-Western Saudi Arabia

Saudi Medical Journal

Volumn 25, Issue 10, 2004, Pages 1433-1438

  Ayoola, Ayobanji E ^a,b   Ageely, Hussein M ^a   Gadour, Mohammed O ^a   Pathak, Ved P ^a  

^a King Fahad Central Hospital   (Saudi Arabia)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHA EDULIS EXTRACT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM DETECTION; BARRETT ESOPHAGUS; CHILD; CHRONIC GASTRITIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DUODENITIS; DUODENUM ULCER; DYSPEPSIA; ESOPHAGITIS; ESOPHAGUS CANCER; FEMALE; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; INTESTINE ENDOSCOPY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PEPTIC ULCER; PREVALENCE; PROSPECTIVE STUDY; SAUDI ARABIA; STOMACH BIOPSY; STOMACH CANCER; STOMACH DISEASE; STOMACH LYMPHOMA; STOMACH ULCER; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; CONFIDENCE INTERVALS; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 7244231405     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-S128.
2. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993; 22: 73-78.
3. Tytgat GNJ, Lee A, Graham DY. The role of infectious agents in peptic ulcer disease. Gastroenterol Int 1993; 6: 76-89.
4. Wotherspoon AC, Oritz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-789.
6. Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ Jr et al. Seroepidemiology of Helicobacter pylori infection in India: Comparison of developing and developing countries. Dig Dis Sci 1991; 36: 1084-1088.
7. Vedhuyzen Van Zanten SJO. Do socio-economic status, marital status and occupation influence the prevalence of Helicobacter infection? Aliment Pharmacol Ther 1995; 9 (Suppl 2): 41-44.
8. Fallone CA, Barkum AN, Gottke MU, Best LM, Loo VG, Vedhuyzen Van Zanten S, et al. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal disease. Am J Gastroenterol 2000; 95: 659-669.
9. Ayoola EA, Rashed RS, Mofleh IA, Faleh FZ, Laajam M. Diagnostic yield of upper gastrointestinal endoscopy in relation to age and gender: a study of 10112 Saudi patients. Hepatogastroenterology 1996; 43: 409-415.
10. Morad NA, Ahmed M, Wabel A, Foli AK. Helicobacter pylori associated dyspepsia in 208 patients from Southern Saudi Arabia. Annals of Saudi Medicine 1993; 13: 340-343.
11. Rashed RS, Ayoola EA, Mofleh IA, Chowdhury MN, Mahmood K, Faleh FZ. Helicobacter pylori and dyspepsia in an Arab population. Trop Geogr Med 1992; 44: 304-347.
12. Mahmood K, Chowdhury MN, Ayoola EA, Al-Mofleh IA, Al-Rashed RS, Al-Faleh FZ. Helicobacter pylori: histological and cultural correlation in chronic gastritis. Trop Gastroenterol 1991; 12: 188-191.
13. Al-Moagel MA, Evan DG, Abdul-Ghani ME, Adam E, Evans DJ Jr, Malaty HM et al. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudi Arabia and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol 1990; 85: 944-948.
14. Satti MB, Twum-Darso K, Al-Frehi HM Ibrahim EM, Al-Gindan Y, Al-Quorain A et al. Helicobacter pylori associated upper gastrointestinal disease in Saudi Arabia; a pathologic evaluation of 298 endoscopic biopsies from 201 consecutive patients. Am J Gastroenterol 1990; 85: 527-531.
15. Al-Frehi HM, Al-Quorain A, Al-Gindan Y Ibrahim EM, Satti MB, Twum-Danso K, et al Campylobacter pylori in Saudi patients undergoing upper gastrointestinal endoscopy: Prevalence and effect of conventional therapy Hepatogastroenterol 1989; 36: 516-518.
16. Zaman R, Hossain J, Zawawi T, Thomas J, Gilpin C, Dibb WL. Diagnosis of Helicobacter pylori: A study in Western Province of Saudi Arabia. Saudi Med J 1995; 16: 552-555.
17. Gunaid AA, Hassan NA, Murray-Lyon I. Prevalence and risk factors for Helicobacter pylori infection among Yemeni dyspeptic patients. Saudi Med J 2003; 24: 512-517.
18. Mendall MA, Northfield TC. Leading article: Transmission of Helicobacter pylori infection. Gut 1995; 37: 1-3.
19. Feldman RA, Eccersley AJP, Hardie JM. Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio. Br Med Bull 1998; 54: 39-53.
20. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991; 6: 209-222.
21. Gumie MAB, Abdou FY. The value of endoscopic biopsy in non-ulcer dyspepsia. Saudi Med J 1993; 14: 142-145.
22. Stanghellini V, Tosetti C, De Giorgio R, Barbara G, Salviolo B, Corinaldasi R. How should Helicobacter pylori negative patients be managed? Gut 1999; 45: (Suppl 1) 132-135.
23. Laine L, Hopkins RJ, Giarardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? Am J Gastroenterol 1998; 93: 1409-1415.
24. Higuchi K, Arakawa T, Fujiwara Y, Uchida T, Tominaga K, Watanabe T et al. Is Helicobacter pylori-negative duodenal ulcers masked by the high prevalence of Helicobacter pylori infection in the general population? Am J Gastroenterol 1999; 94: 3083-3084.
25. El-Bagir Ahmed M, Morad N, Al-Knawy B. Identifying Helicobacter pylori: Is H and E staining enough? Saudi Med J 1997; 18: 264-266.
26. Peterson WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine bismuth citrate plus clarithromycin is effective in healing duodenal ulcers, eradicating Helicobacter pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996; 10: 251-256.
27. Lanza F, Ciociola AA, Sykes D. Ranitidine bismuth citrate plus clarithromycin is effective in eradicating Helicobacter pylori healing duodenal ulcers and preventing ulcer relapse. Gastroenterology 1996; 110: A172.
28. Ching CK, Wong BC, Kwok E, Ong L, Covacci A, Lam SK et al. Prevalence of Cag A-bearing Helicobacter pylori strains detected by the anti-Cag A assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996; 91: 949-953.
29. Al-Fadda M, Powe J, Rezeig M, Al-Nazer M, Al-Rajhi AA, Baynton R. Comparison of carbon-14 urea breath test and rapid urease test with gastric biopsy for identification of Helicobacter pylori. Annals of Saudi Medicine 2000; 20: 170-172.
30. Jaakkimainen RL, Bole E, Tudiver F. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis. Br Med J 1999; 319: 1040-1044.
31. Working party of the European Helicobacter pylori Study Group. Tests used to asses Helicobacter pylori infection. Gut 1997; 41 (Suppl 2): S10-S18.